ORAL CARE COMPOSITION
    5.
    发明申请

    公开(公告)号:US20220031590A1

    公开(公告)日:2022-02-03

    申请号:US16325802

    申请日:2016-08-18

    申请人: SYMRISE AG

    IPC分类号: A61K8/42 A61Q11/00

    摘要: The present invention relates to oral care compositions for altering the composition of oral biofilms so that the proportion of microorganisms, which are detrimental to oral health, is reduced while the proportion of health-promoting microorganisms is increased. Furthermore, oral care products comprising the composition according to the invention in an amount sufficient to alter the composition of oral biofilms to promote dental health are provided.

    PROBIOTICS FOR ALTERING THE COMPOSITION OF ORAL BIOFILMS

    公开(公告)号:US20190290705A1

    公开(公告)日:2019-09-26

    申请号:US16070573

    申请日:2017-01-18

    申请人: SYMRISE AG PROBI AB

    摘要: The present invention relates to a certain microorganism for altering the composition of oral biofilms, in particular for use in the treatment and/or prevention of dental caries and/or periodontal disease.In particular, the present invention relates to a microorganism for use as a probiotic agent for altering the bacterial composition of oral biofilms derived from saliva, preferably for reducing the proportions of Gram-negative anaerobic genera and/or increasing the proportions of aerobic or facultatively anaerobic genera.Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising the microorganism as probiotic agents as well as a method of production thereof.

    ACTIVE AGENTS FOR SKIN AND HAIR CARE WITH SENSORY MODIFYING PROPERTIES

    公开(公告)号:US20220096347A1

    公开(公告)日:2022-03-31

    申请号:US17428350

    申请日:2019-02-04

    申请人: SYMRISE AG

    摘要: The present invention primarily relates to the use of a fatty acid ester or of a mixture of two or more fatty acid esters or of a mixture comprising one or more fatty acid esters, wherein the fatty acid ester or one, two, three or more, preferably all, of the fatty acid ester(s) is/are selected from the group consisting of 3-hydroxypropyl caprylate, glyceryl monocaprylate, 3-hydroxypropyl undecylenate and glyceryl monoundecylenate, for modifying the sensory properties of a skin care product. The present invention further relates to methods for modifying the sensory properties of a skin care product as well as to methods for manufacturing a skin care product and to particular skin care products.

    JASMOL
    8.
    发明申请
    JASMOL 有权

    公开(公告)号:US20210403830A1

    公开(公告)日:2021-12-30

    申请号:US17294803

    申请日:2018-11-19

    申请人: SYMRISE AG

    摘要: The present invention relates to a composition for reducing malodor, preferably a musty and/or mouldy malodor, methods for producing such a composition and the use of such a composition. Furthermore, the present invention relates to preparations containing such a composition, methods for producing such preparations and their use. The composition comprises the combination of 2-benzylheptanol (jasmol) with a compound selected from (I) 3,5-di-ter-butyl-4-hydroxytoluol (BHT), (II) octadecyl di-ter-butyl-4-hydroxy-hydrocinnamate (Tinogard TS) and (III) pentaerythrityl tetra-di-ter-butyl hydroxyhydrocinnamate (Tinogard TT).

    FATTY ACID ESTERS AS ANTI-MALASSEZIA AGENTS

    公开(公告)号:US20220142885A1

    公开(公告)日:2022-05-12

    申请号:US17428309

    申请日:2019-02-04

    申请人: SYMRISE AG

    摘要: The present invention primarily relates to a fatty acid ester or mixture of two or more fatty acid esters or mixture comprising one or more fatty acid esters, wherein the fatty acid ester or one, two, three or more, preferably all, of the fatty acid ester(s) is/are selected from the group consisting of 3-hydroxypropyl caprylate, glyceryl monocaprylate, 3-hydroxypropyl undecylenate and glyceryl monoundecylenate, for use in the treatment of an excess of Malassezia on the skin surface of mammals, preferably of humans. The present invention further relates to particular mixtures or products, and to the cosmetic, non-therapeutic use of fatty acid esters or of mixtures or products comprising fatty acid esters as defined herein to reduce the amount of Malassezia on the skin surface of mammals, preferably of humans.